Related Experiment Video
Updated: Aug 8, 2026

09:04
In Vitro ELISA Test to Evaluate Rabies Vaccine Potency
Published on: May 11, 2020
[Problems in production, control and utilization of veterinary vaccines in the developing countries]
Summary
Developing countries are pursuing national self-sufficiency in veterinary vaccines despite significant logistical and production challenges. Pragmatic solutions enable low-cost vaccine production, enhancing global animal health accessibility.
Area of Science:
- Veterinary Medicine
- Vaccinology
- Public Health
Context:
- Developing countries prioritize national self-sufficiency in veterinary vaccine production due to political factors.
- Significant challenges exist in logistic distribution, including personnel shortages, funding issues, inadequate infrastructure, and limited cold chain facilities.
- Production hurdles involve difficulties in sourcing supplies, unreliable utilities (water, electricity), and challenges in obtaining animals for quality control.
Purpose:
- To outline the challenges faced by developing nations in achieving self-sufficiency in veterinary vaccine production.
- To identify pragmatic solutions and strategies implemented to overcome these obstacles.
- To assess the feasibility and cost-effectiveness of domestic veterinary vaccine manufacturing.
Summary:
- Developing countries face multifaceted challenges in veterinary vaccine logistics and production, including infrastructure, personnel, and supply chain issues.
- Pragmatic solutions include site segregation, foreign technical assistance, simplified techniques, bulk manufacturing, thermostabilization research, combined vaccines, and adherence to international standards (WHO/FAO/OIE).
- Despite obstacles, these strategies result in significantly lower production costs compared to foreign private industry.
Impact:
- Enables cost-effective domestic production of essential veterinary vaccines, improving animal health and food security in developing nations.
- Promotes the adoption of sustainable and reliable vaccine manufacturing practices tailored to resource-limited settings.
- Facilitates knowledge transfer and capacity building in veterinary vaccinology within developing countries.
Related Concept Videos
Vaccinations
Overview
Microorganisms in Medicine and Therapeutics
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
Vaccine Production
Vaccine production involves a sequence of upstream and downstream processes to generate a safe and effective immunological product. It begins with cultivating microorganisms, such as viruses or bacteria, to obtain antigenic material. For viral vaccines, mammalian host cells are grown in bioreactors and subsequently infected with the target virus. The virus replicates within the host cells, which are lysed to release viral particles. This lysate is then clarified through filtration or...
Smallpox
Smallpox is a severe contagious disease caused by the Variola major virus, a double-stranded DNA member of the Poxviridae family.Variola major transmission occurs primarily via inhalation of virus-laden droplets or direct contact with infectious scabs. The incubation period averages approximately seven days, although it may range from 7 to 17 days depending on the inoculum and host factors.Clinically, the prodromal phase is marked by an abrupt onset of high fever, malaise, headache, and myalgia.

